Newsletter Signup | Join Community
Research suggests conflicting results with Interferon treatment for polycythemia vera and essential thrombocythemia.
Inrebic represents a new treatment option for Jakafi-resistant Myelofibrosis and significantly reduces spleen volumes.
Clinical trials are ongoing evaluating Pacritinib in MF - no significant updates were released at ASH 2019.
In addition to improving long term survival Jakafi® improves MF caused fatigue, spleenomegaly and kidney function.
Dr. Ruben Mesa, Mays Cancer Center answered questions about the management of polycythemia vera and myelofibrosis.
Understand the symptoms, diagnosis, treatment & management of Polycythemia Vera.
Connect with others and learn about lymphoma, leukemia, hodgkin's disease and myeloproliferative neoplasms.
Is it worth going to someone who specializes in the treatment of MPNs like PV MF or ET?
MF - ELZONRISTM (tagraxofusp; SL-401) trials in MF look promising: https://ir.stemline…
Read the news update about the risk of lymphoma with treatment; has anyone's doctor discussed this…